SCHEMBL19328343

SCHEMBL19328343

O=C(O)CCNC(=S)Nc1ccc(I)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.65
CA2 P00918 3/20 0.65
IDO1 P14902 1/20 0.50
ABAT P80404 1/20 0.50
GPR174 Q9BXC1 1/20 0.48
LMNA P02545 5/20 0.47
ALDH1A1 P00352 4/20 0.47
KMT2A Q03164 2/20 0.46
GAA P10253 3/20 0.45
MAPT P10636 3/20 0.45
ALOX12 P18054 1/20 0.45
FOLH1 Q04609 1/20 0.45
RAB9A P51151 2/20 0.45
NPC1 O15118 1/20 0.45
MAOA P21397 1/20 0.45
MAOB P27338 1/20 0.45
MEN1 O00255 1/20 0.44
MAPK1 P28482 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
CYP1A2 P05177 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4308791 0.84 CA1 (0.65) CA1CA2LMNAALDH1A1KMT2A
SCHEMBL24329888 0.77 LMNA (0.67) IDO1GPR174LMNAALDH1A1KMT2A
SCHEMBL23121013 0.75 POLB (0.59) CA1CA2ALDH1A1KMT2AMAPT
SCHEMBL11672644 0.75 CA1 (0.68) CA1CA2ABATLMNAALDH1A1
SCHEMBL7390323 0.75 ITGB3 (0.76) CA1CA2ITGB3ITGA2B
SCHEMBL7822000 0.74 CYP1A1 (0.70) CA1CA2ALDH1A1KMT2AMAPT
SCHEMBL11519940 0.73 ALDH1A1 (0.67) CA1CA2ABATLMNAALDH1A1
SCHEMBL7390331 0.73 CA2 (0.58) CA1CA2ABATLMNAALDH1A1
SCHEMBL3451684 0.73 LMNA (0.64) IDO1LMNAALDH1A1KMT2AMAPT
SCHEMBL8879067 0.73 CA1 (0.61) CA1CA2FOLH1MAPK1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10080757-B2 Inhibitors of UDP-galactopyranose mutase WISCONSIN ALUMNI RESEARCH FOUNDATION 2018-09-25 US disclosed
US-20170258805-A1 INHIBITORS OF UDP-GALACTOPYRANOSE MUTASE WISCONSIN ALUMNI RESEARCH FOUNDATION 2017-09-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170258805-A1 INHIBITORS OF UDP-GALACTOPYRANOSE MUTASE UGDH, GALE, UGGT1 CA1 4286/4885CA2 3372/4885IDO1 190/4885
US-10080757-B2 Inhibitors of UDP-galactopyranose mutase UGDH, GALE, UGGT1 CA1 4286/4885CA2 3372/4885IDO1 190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.